Clinical trials
Observational Genetic Risk Score trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 7 |
| Recruiting | 7 |
| Unknown status | 7 |
| Completed | 5 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 |
| Second Xiangya Hospital of Central South University | 2 |
| AHEPA University Hospital | 1 |
| Ambry Genetics | 1 |
| Aristotle University Of Thessaloniki | 1 |
| Catholic University of the Sacred Heart | 1 |
| D'Or Institute for Research and Education | 1 |
| Far Eastern Memorial Hospital | 1 |
| Ferrer inCode, S.L. | 1 |
| IRCCS San Raffaele | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Risk Score | 28 |
| Genetic Predisposition to Disease | 6 |
| Coronary Artery Disease | 4 |
| Diabetes Mellitus, Type 1 | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Breast Neoplasms | 2 |
| Coronary Disease | 2 |
| Obesity | 2 |
| Prostatic Neoplasms | 2 |
| Abortion, Habitual | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.